Free delivery over $100 Learn more

30 days return period Learn more
SKU: 0276ATC

KP-4 Human Pancreas Epithelial Cells

Tumor Cell Lines > Pancreatic Cancer Cell Lines

Product Type: Human Pancreas Cancer Cell Lines

Species: Human

Cell Type: Epithelial Cells

Source Organ: Pancreas

$1,249.00
Size

Care information

Display general product information or specific product information using metafields.

Delivery and Shipping

Add some general information about your delivery and shipping policies.

Cell Name: KP-4

Human tumor cell line secreting parathyroid hormone-related peptide (PTHrP) established from pancreatic tumor. Pancreatic ductal cell carcinoma, Tumor cell line secreting parathyroid hormone-related peptide (PTHrP). Transplantable to nude mice.

  • Description
    KP-4 is a human pancreatic ductal cell carcinoma (PDAC) cell line derived from a 50-year-old Japanese male patient with metastatic PDAC in ascitic fluid. The cells exhibit epithelial-like morphology and show low expression of E-cadherin and high expression of vimentin mRNA. KP-4 cells secrete parathyroid hormone-related peptide (PTHrP), which makes them a valuable model for studying PTHrP regulation and its role in cancer. These cells are highly metastatic and can metastasize to the liver and lungs. KP-4 cells have a modal chromosome number of approximately 52–54 and carry a KRAS mutation (p.Gly12Asp). The cells have a doubling time of around 27 hours.
  • Product Name
    KP-4
  • Product Type
    Human Pancreas Cancer Cell Lines
  • Species
    Human
  • Cell Type
    Epithelial-like
  • Source Organ
    Pancreas
  • Product Type
    Human Pancreas Cancer Cell Lines
  • Growth Conditions
    37 °C, 5% CO2
  • Application
    KP-4 can be used to investigate how cancer cells evade apoptosis.. It was found that PI3K inhibitor can inactivate Akt, resulting in inhibition of cell proliferation in human pancreatic ductal carcinoma cell lines, PSN-1[a], PANC-1[b], and KP-4, and cell cycle arrested in the G1 phase with the PI3K inhibitor. Further studies using KP-4 may clarify whether the PI3K-AKT pathway supports proliferation in pancreatic ductal carcinoma. Otherwise, KP-4 can be applied in the field of identifying mutants and essential gene profiles of human pancreatic carcinoma for screening target genes and developing RNA drugs.
  • Size/Quantity
    1 vial
  • Recommended Medium And Supplement

    RPMI 1640 + 10% FBS
  • Shipping Conditions
    Dry Ice
  • Storage
    Liquid Nitrogen
  • Biosafety Level
    1

Payment & Security

Payment methods

    Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.

    • Visit our support center

      Expert help & advice

    • Check your order status

      Updates & tracking

    • Returns & exchanges

      All you need to know

    • Price-match guarantee

      Our promise to you